NPPES file of Aug 9, 2026

Matthew James Everly, PHARMD

Pharmacotherapy Pharmacist · Los Angeles, CA

Matthew James Everly, PHARMD is a pharmacotherapy pharmacist with a practice address in Los Angeles, California, and NPI 1164760229, issued on Jan 24, 2013. Check the license (California 63305, as entered in NPPES) with the California board that licenses this profession; the federal record below is the public data PlainDoctor holds for this provider.

Record from CMS NPPES, file of Aug 9, 2026 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1164760229
Name
Matthew James Everly
Credential
PHARMD
Primary taxonomy
Pharmacotherapy Pharmacist 1835P1200X
License number
63305 CA
Self-reported in NPPES; status is on the state search
Practice location
2038 Corinth Ave, Los Angeles, CA 90025
Phone
(310) 896-8609
Enumerated
Jan 24, 2013
Record last updated
Jan 24, 2013 (not updated in 13 years: call before relying on the address or phone)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Verify Matthew James Everly in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich California board licenses this profession
    Search for license 63305    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

Pharmacotherapy Pharmacist providers in California

There are 605 pharmacotherapy pharmacist records in California. No Medicare prescribing, quality score, industry payment or hospital affiliation is published for this NPI.

All 605 in California → Every provider in Los Angeles →

Other pharmacotherapy pharmacist records in California

  1. Danny Abifadel, PHARM.D.Chico, CA1427245455
  2. Nidhu Abraham, PHARM.D., BCPSPalo Alto, CA1023543717
  3. Wayne Adams, PHARMD.Pasadena, CA1215760178
  4. Edwin Adlam, PHARMD, CGPSanta Barbara, CA1225026305
  5. Dele Akao, PHARM.D., BCPSValencia, CA1013127588
  6. Barbara Albrecht, PHARM. D.Los Angeles, CA1811083876
  7. Victoria Aldridge, PHARM.D.San Diego, CA1245247733
  8. Chris AmadiSacramento, CA1902655129
  9. Cheryl Amin, PHARMDSan Francisco, CA1780748715
  10. Allen AmirantNorth Hills, CA1639273659

Common questions

What is Matthew James Everly, PHARMD's NPI number?

Matthew James Everly, PHARMD's National Provider Identifier (NPI) is 1164760229, issued on Jan 24, 2013. An NPI identifies a provider in billing; it is not a license.

Where is Matthew James Everly, PHARMD located?

The NPPES record lists a practice address at 2038 Corinth Ave, Los Angeles, CA, 90025. Phone: (310) 896-8609. Providers update this record themselves, so call before visiting.

How can I verify Matthew James Everly, PHARMD's license?

NPPES lists California license number 63305, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. An NPI identifies who bills; it is not a license.

Written with AI tools from the named public files; every figure is computed from those files (how it is made).

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.